Pre and post analytical errors in lipid determination

  • S. Narayanan
Quality Control


A number of pre analytical variables affect lipid determinations. These include posture during blood sampling, the duration of tourniquet application and fasting, the time of day when blood is collected, the concentration and type of anticoagulant used for blood collection to name just a few. Effect of life style such as diet, alcohol and caffeine consumption, smoking, and exercise influence lipid determinations. Disease states such as infection, diabetes, nephrotic syndrome and heart disease culminating in myocardial infarction and conditions such as obesity and pregnancy influence lipid profiles. A variety of drugs ranging from diuretics to oral contraceptives to immunosuppressive drugs induce alterations in the patient's lipid profile. Post analytical variables impacting on the interpretation of laboratory data such as in the determination of the true mean of a lipid constituent would depend on the number of specimens analyzed, the analytical variability of the method and approaches to handling data such as the use of relative range to estimate the effect of biological variability on the computed mean value.

Key words

Analytical errors Lipid metabolism 


  1. 1.
    Tan, M.H., Wilmshurst, E.G., Gleason, R.E. and Soldner, J.S. (1973) Effect of posture on serum lipids. N. Engl. J. Med. 289, 416–419.PubMedGoogle Scholar
  2. 2.
    Young, D.S. (1979) Biological variability in “Chemical diagnosis of disease” Eds. Brown S.S., Mitchell F.L., Young D.S. Elsevier, New York p 1–113.Google Scholar
  3. 3.
    Howes, L.G., Krum, H. and Louis, W.J. (1987) Plasma cholesterol levels are dependent on sympathetic activity. J. Hypertension 5 (Supplement) S: 361–363.Google Scholar
  4. 4.
    Cooper, G.R., Myers, G.L., Smith, J.J. and Sampson, E.J. (1988) Standardization of lipid, lipoprotein and apolipoprotein measurements. Clin. Chem. 34, B95-B105.PubMedGoogle Scholar
  5. 5.
    Cloey, T., Bachorik, P.S., Becker, D., Finney, C., Lowry, D. and Sigmund, W. (1990) Reevaluation of serum-plasma difference in total cholesterol concentration. J. Am. Med. Assocn. 263, 2788–2789.CrossRefGoogle Scholar
  6. 6.
    Cooper, G.R., Myers, G.L., Smith, J. Schlant, R.C. (1992) Blood lipid measurements: Variations and practical utility. J. Am. Med. Assocn. 267, 1652–1660.CrossRefGoogle Scholar
  7. 7.
    Harris, W.S., Connor, W.E., Illingworth, D.R., Rothrock, D.W. and Foster, D.M. (1990) Effects of fish oil on VLDL triglyceride kinetics in humans. J. Lipid Res. 31, 1549–1558.PubMedGoogle Scholar
  8. 8.
    Sacks, F.M., Ornish, D., Rosner, B., Mclanahan, S., Castelli, W.P. and Kass, E.H. (1985) Plasma lipoprotein levels in vegetarians. J. Am. Med. Assocn. 254, 1337–1341.CrossRefGoogle Scholar
  9. 9.
    Taskinin, M.R., Nikkila, E.A., Valimaki, M. et al (1987) Alcohol-induced changes in serum lipoproteins and in their metabolism. Am. Heart J. 113, 458–464.CrossRefGoogle Scholar
  10. 10.
    Van Dusseldorp, M., Katan, M.B. and Demacker, P.N.M. (1990) Effect of decaffeinated versus regular coffee on serum lipoproteins: a 12-week double-blind trial. Am. J. Epedimiol. 132, 33–40.Google Scholar
  11. 11.
    Craig, W.Y., Palomaki, G.E. and Haddow, J.E. (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Brit. Med. J. 298, 784–788.PubMedGoogle Scholar
  12. 12.
    Hardman, A.E., Hudson, A., Jones, P.R.M. and Norgan, N.G. (1989) Brisk walking and plasma high-density lipoprotein cholesterol concentration in previously sedentary women. Brit. Med. J. 299, 1204–1205.PubMedGoogle Scholar
  13. 13.
    Newman, B., Selby, J.V., Quesenberry, C.P., King, M.C., Freidman, G.D., and Fabsitz, R.R. (1990) Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am. J. Public Health 80, 675–678.PubMedCrossRefGoogle Scholar
  14. 14.
    Knopp, R.H., Walden, C.E., Whal, P.W. et al. (1985) Effect of postpartum lactation on lipoprotein lipids and apoproteins. J. Clin. Endocrinol. Metab. 60, 542–547.PubMedGoogle Scholar
  15. 15.
    Joven, J., Villabona, C. and Vilella, E. (1990) Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N. Engl. J. Med. 323, 579–584.PubMedGoogle Scholar
  16. 16.
    Karadi, I., Romics, L., Palos, G. et al. (1989) LP(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin. Chem. 35, 2121–2123.PubMedGoogle Scholar
  17. 17.
    Narayanan, S. (1984) Biochemistry and clinical relevance of lipoprotein X. Ann. Clin. Lab. Sci. 14, 371–374.PubMedGoogle Scholar
  18. 18.
    Alvarez, C. and Ramos, A. (1986) Lipids, lipoprotein and apolipoproteins in serum during infection. Clin. Chem. 32, 142–145.PubMedGoogle Scholar
  19. 19.
    Walton, K.W., Scott, P.J., Dykes, P.W. and Davies, J.W.L. (1965) The significance of alteration in serum lipids in thyroid dysfunction. II. Alteration of metabolism and turnover of131I-low density lipoprotein in hypothyroidism and thyrotoxicosis. Clin. Sci. 29, 217–238.PubMedGoogle Scholar
  20. 20.
    Laakso, M., Sarlund, H. and Mykkanen, L. (1990) Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10, 223–231.PubMedGoogle Scholar
  21. 21.
    Gore, J.M., Goldberg, R.J., Matsumoto, A.S., Castelli, W.P., Mc Namara, P.M. and Dalen, J.E. (1984) Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am. J. Cardiol. 54, 722–725.PubMedCrossRefGoogle Scholar
  22. 22.
    McKenney, J.M., Wright, J.T., Goodman, R.P., et al. (1986) The effect of low dose of hydrochlorothiazide on blood pressure, serum potassium and lipoproteins. Pharmacotherapy 6, 179–184.PubMedGoogle Scholar
  23. 23.
    Bush, T.L., Fried, L.P. and Barret-Conner E. (1988) Cholesterol, lipoproteins and coronary heart disease in women. Clin. Chem. 34, B60–70.PubMedGoogle Scholar
  24. 24.
    Ballantyne, C.M., Podet, E.J., Patsch, W.P., et al. (1989) Effects of cyclosporine therapy on plasma lipoprotein levels. J. Am. Med. Assocn. 262, 53–56.CrossRefGoogle Scholar
  25. 25.
    Woodcock, B.G. and Rietbrock, N. (1984) Betablocker induced changes in the cholesterol: High density lipoprotein cholesterol ratio and risk of coronary heart disease. Klin. Wochenschr. 62, 843–849.PubMedCrossRefGoogle Scholar
  26. 26.
    Laboratory standardization panel, National cholesterol education program, National Heart Lung and Blood Institute. Recommendations for improving cholesterol measurement Bethesda, Md: National Cholesterol Education Program February (1990) 1–81, NIH Publication 90-2964.Google Scholar
  27. 27.
    Bookstein, L., Gidding, S.S., Danovan, M. and Smith, F.A. (1990) Day-to-day variability of serum cholesterol, triglyceride, and high density lipoprotein cholesterol levels: Impact on the assessment of risk according to the National Cholesterol Education Program Guidelines. Arch. Intern. Med. 150, 1653–1657.PubMedCrossRefGoogle Scholar
  28. 28.
    Bachorik, P.S. (1989) Measurement of total cholesterol, HDL-cholesterol and LDL-cholesterol. In “Clinics in laboratory Medicine”, Guest Eds. Rifkind, B.M., Lippel, K.W.A. Saunders, New York 9 (1), 61-p. 61–72.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 1996

Authors and Affiliations

  • S. Narayanan
    • 1
  1. 1.Department of PathologyNew York Medical College-Metropolitan Hospital CenterNew YorkU.S.A.

Personalised recommendations